366.7K
Downloads
255
Episodes
The Cardiovascular CME podcast is a free educational offering from Mayo Clinic, featuring content geared towards physicians, physician assistants, and nurse practitioners who are interested in exploring a multitude of cardiology-related topics. Tune in and subscribe to explore today’s most pressing cardiology topics with your colleagues at Mayo Clinic and gain valuable insights that can be directly applied to your practice. No CME credit offered for podcast episodes at this time.
Episodes
Tuesday Oct 12, 2021
Tuesday Oct 12, 2021
LVAD – Who Needs It?
Guest: Andrew (Drew) N. Rosenbaum, M.D. (@werDrD)
Host: Malcolm R. Bell, M.D.
About 6.5 million people over the age of 20 years in the U.S. have heart failure. That number is estimated to grow to about 8 million by 2030. Of those patients, about 300,000 would potentially benefit from left ventricular assist device (LVAD) therapy. Among patients with advanced heart failure, 66% to 75% would have comorbidities that would preclude benefit from LVAD therapy, so approximately 75,000 to 100,000 patients in the U.S. would be potentially eligible for LVAD therapy.
Joining us today to discuss LVADs is Andrew (Drew) N. Rosenbaum, M.D., a cardiologist at Mayo Clinic in Rochester, Minnesota.
Specific topics discussed:
- Types of left ventricular assist devices: durable, destination therapy, bridge to transplantation
- Who benefits from LVAD and why
- LVAD durability
- Age limitations for LVAD therapy
- Inappropriate candidates for LVAD
- End-stage renal disease, LVAD and dialysis
- When to consider referral for LVAD therapy
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV.
No CME credit offered for this episode.
Podcast episode transcript found here.